La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Parkinson Disease (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinson Disease (immunology) < Parkinson Disease (metabolism) < Parkinson Disease (microbiology)  Facettes :

List of bibliographic references indexed by Parkinson Disease (metabolism)

Number of relevant bibliographic references: 290.
[60-80] [0 - 20][0 - 50][80-100]
Ident.Authors (with country if any)Title
000B96 (2014) Kenneth Marek [États-Unis] ; John Seibyl [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] ; Chris Hyson [Canada] ; Danna Jennings [États-Unis]Longitudinal follow-up of SWEDD subjects in the PRECEPT Study
000C16 (2014) Florian Holtbernd [États-Unis] ; Jean-François Gagnon [Canada] ; Ron B. Postuma [Canada] ; YILONG MA [États-Unis] ; Chris C. Tang [États-Unis] ; Andrew Feigin [États-Unis] ; Vijay Dhawan [États-Unis] ; Mélanie Vendette [Canada] ; Jean-Paul Soucy [Canada] ; David Eidelberg [États-Unis] ; Jacques Montplaisir [Canada]Abnormal metabolic network activity in REM sleep behavior disorder
000C30 (2013) Hongliu Ding ; Kaltra Dhima ; Kaitlin C. Lockhart ; Joseph J. Locascio ; Ashley N. Hoesing ; Karen Duong ; Ana Trisini-Lipsanopoulos ; Michael T. Hayes ; U. Shivraj Sohur ; Anne-Marie Wills ; Brit Mollenhauer ; Alice W. Flaherty ; Albert Y. Hung ; Nicte Mejia ; Vikram Khurana ; Stephen N. Gomperts ; Dennis J. Selkoe ; Michael A. Schwarzschild ; Michael G. Schlossmacher ; Bradley T. Hyman ; Lewis R. Sudarsky ; John H. Growdon ; Clemens R. ScherzerUnrecognized vitamin D3 deficiency is common in Parkinson disease
000C36 (2013) Sungwon Han [Canada] ; Christopher Auger ; Zachary Castonguay ; Varun P. Appanna ; Sean C. Thomas ; Vasu D. AppannaThe unravelling of metabolic dysfunctions linked to metal-associated diseases by blue native polyacrylamide gel electrophoresis.
000C37 (2013) Kelvin C. Luk [Canada] ; Vladimir V. Rymar ; Pepijn Van Den Munckhof ; Stefan Nicolau ; Claude Steriade ; Panojot Bifsha ; Jacques Drouin ; Abbas F. SadikotThe transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress.
000C38 (2013) Philippe Huot [Canada] ; Susan H. FoxThe serotonergic system in motor and non-motor manifestations of Parkinson's disease.
000C43 (2013) Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Susan H. Fox ; Jonathan M. BrotchieThe pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease.
000C44 (2013) Dimitri Ryczko [Canada] ; Réjean DubucThe multifunctional mesencephalic locomotor region.
000D07 (2013) Susanna Ekholm-Reed ; Matthew S. Goldberg ; Michael G. Schlossmacher ; Steven I. ReedParkin-Dependent Degradation of the F-Box Protein Fbw7β Promotes Neuronal Survival in Response to Oxidative Stress by Stabilizing Mcl-1
000D19 (2013) Susan H. Fox [Canada]Non-dopaminergic treatments for motor control in Parkinson's disease.
000D21 (2013) Hu Xu [Canada] ; Louiza Belkacemi ; Mandar Jog ; Andrew Parrent ; Matthew O. HebbNeurotrophic factor expression in expandable cell populations from brain samples in living patients with Parkinson's disease.
000D34 (2013) Pierre O. Poliquin [Canada] ; Jingkui Chen [Canada] ; Mathieu Cloutier [Canada] ; Louis-Éric Trudeau [Canada] ; Mario Jolicoeur [Canada]Metabolomics and In-Silico Analysis Reveal Critical Energy Deregulations in Animal Models of Parkinson’s Disease
000D50 (2013) Naomi P. Visanji [Canada] ; Joanna F. Collingwood ; Mary E. Finnegan ; Anurag Tandon ; Emily House ; Lili-Naz HazratiIron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophy.
000D90 (2013) Jovana Lubarda [Canada] ; Sarah E. Groleau ; Nancy Thomas ; Mark A. Ferro ; Ram K. Mishra ; Joseph P. GabrieleDysregulation of novel catecholamine-regulated protein 40 (CRP40) in Parkinson's disease patients.
000E23 (2013) Leigh Christopher [Canada] ; Connie Marras [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Robert Chen [Canada] ; Isabelle Boileau [Canada] ; Barbara Segura [Canada, Espagne] ; Oury Monchi [Canada] ; Anthony E. Lang [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada]Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson’s disease with mild cognitive impairment
000E37 (2013) Golnasim Riahi ; Marc Morissette ; Pershia Samadi ; Martin Parent ; Thérèse Di PaoloBasal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia.
000E81 (2013) Tiago A. Mestre [Canada] ; Mateusz Zurowski ; Susan H. Fox5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders.
000F06 (2013) Lorraine V. Kalia [Canada] ; Suneil K. Kalia [Canada] ; Pamela J. Mclean ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada]α‐Synuclein oligomers and clinical implications for Parkinson disease
001004 (2013) Andrea Gold [Canada] ; Zorbey T. Turkalp [Canada] ; David G. Munoz [Canada]Enteric alpha‐synuclein expression is increased in Parkinson's disease but not Alzheimer's disease
001021 (2013) Pankaj A. Agarwal [Canada] ; A. Jon Stoessl [Canada]Biomarkers for trials of neuroprotection in Parkinson's disease
001133 (2012) Maria Xilouri [Grèce] ; Elli Kyratzi ; Pothitos M. Pitychoutis ; Zoi Papadopoulou-Daifoti ; Celine Perier ; Miquel Vila ; Matina Maniati ; Ayse Ulusoy ; Deniz Kirik ; David S. Park ; Keiji Wada ; Leonidas StefanisSelective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease (metabolism)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinson Disease (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (metabolism)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022